Results 1 to 10 of about 70,006 (218)

The chromosomes and causation of human cancer and leukemia: XXXVIII. Cytogenetic experience in Ph1-negative chronic myelocytic leukemia (CML)

American Journal of Hematology, 1979
Sei-Ichi Kohno, Syuiti Abe
exaly  

Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species

Journal of Cellular and Molecular Medicine, 2018
Dafne Moreno-Lorenzana, Peter A Crooks, Mónica L Guzman   +2 more
exaly  

A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction

Journal of Theoretical Biology, 2004
Helen Moore
exaly  

CML as a Second Cancer after CLL

Ca-A Cancer Journal for Clinicians, 1981
exaly  

Novel oral transforming growth factor‐β signaling inhibitor EW‐7197 eradicates CML‐initiating cells

Cancer Science, 2016
Kazuhito Naka, Cheng Hua Jin, Dong－Hyun Kim   +2 more
exaly  

Arabidopsis Calmodulin-Like Proteins, CML15 and CML16 Possess Biochemical Properties Distinct from Calmodulin and Show Non-overlapping Tissue Expression Patterns

Frontiers in Plant Science, 2017
Kim Munro, Wayne A Snedden, Snedden Wayne A   +2 more
exaly  

Author's Reply: CML as a Second Cancer after CLL

Ca-A Cancer Journal for Clinicians, 1981
exaly  

Prediction of CML contents in the Maillard reaction products for casein-monosaccharides model

Food Chemistry, 2018
Yoonsook Kim, Kwang-Won Lee, Ho-Young Park   +2 more
exaly  

Growth inhibition of imatinib-resistant CML cells with the T315I mutation and hypoxia-adaptation by AV65 – a novel Wnt/β-catenin signaling inhibitor

Cancer Letters, 2011
Rina Nagao, Miki Takeuchi, Ruriko Tanaka   +2 more
exaly  

EUTOS CML prognostic scoring system predicts ELN-based ‘event-free survival’ better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate

Hematology, 2013
Engin KELKİTLİ, Özlen Bektaş, Ayse Isik   +2 more
exaly